Cecilia Pompili, MD

Leeds Institute of Cancer and Pathology, St James' Institute of Oncology, University of Leeds, Leeds, UK

Dr. Cecilia Pompili is a qualified Thoracic Surgeon who works at Leeds Teaching Hospital Trust, Leeds, UK. She is also an applied health researcher of the Patient Centred Outcomes Group (POG) at the Leeds Institute of Cancer and Pathology of the University of Leeds. The research team focuses on the use of Patient Reported Outcomes, which allow patients to self-report adverse events and symptoms online with immediate integration into their electronic records to support their care and improve patient experiences. 

She received his MD Degree in Medicine and Surgery at the University of Rome, Italy and completed his Thoracic Surgery Residency at the University Politecnica delle Marche, Ancona Italy.

She was Visiting Fellow at the Thoracic Surgery Departments of the Washington University in St Louis, USA and Hotel Dieu Hospital in Paris, France.

Dr Pompili is the Co-chair of the European Society of Thoracic Surgeons (ESTS) Quality of Life and Patient Safety Committee, which has organized two International Symposia at the ESTS Annual Meetings. 

Her research focuses on patient-reported outcomes (PRO) measurement and the impact of different Lung Cancer Treatments on Patients Quality of Life. 

In 2012, she was awarded with the European Young Investigator Award for the best research in the field of thoracic surgery presented during the ESTS Annual Congress. The project was entitled: Preoperative quality of life predicts survival following pulmonary resection in stage I non-small cell lung cancer. She has been conducting methodological projects on the selection of PROMs instruments culminating in different scientific publications.

She is a member of the European Organization for Research and Treatment of Cancer Quality of Life Group (EORTC-QoL) since many years and she is currently co-investigator in a multicenter Phase III study updating the EORTC questionnaire for assessing quality of life in lung cancer patients (QLQ-LC13).

She has lead multicenter studies evaluating the patients’ satisfaction after surgical treatments for lung cancer across different Countries.

Terms of Appointment: October 2019 - September 2021